GM602 Trademark

Trademark Overview

On Monday, January 15, 2007, a trademark application was filed for GM602 with the United States Patent and Trademark Office. The USPTO has given the GM602 trademark a serial number of 77083343. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, June 17, 2017. This trademark is owned by Genervon Biopharmaceuticals LLC. The GM602 trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation for the treatment of central nervous system disorders and peripherial nervous system disorders
gm602

General Information

Serial Number77083343
Word MarkGM602
Filing DateMonday, January 15, 2007
Status800 - REGISTERED AND RENEWED
Status DateSaturday, June 17, 2017
Registration Number3416815
Registration DateTuesday, April 29, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 12, 2008

Trademark Statements

Goods and ServicesPharmaceutical preparation for the treatment of central nervous system disorders and peripherial nervous system disorders
Pseudo MarkGM 602

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 22, 2007
Primary Code005
First Use Anywhere DateWednesday, December 20, 2006
First Use In Commerce DateWednesday, December 20, 2006

Trademark Owner History

Party NameGenervon Biopharmaceuticals LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressPasadena, CA 91106
Party NameGenervon Biopharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMontebello, CA 90640
Party NameGenervon Biopharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMontebello, CA 90640

Trademark Events

Event DateEvent Description
Saturday, June 17, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, June 17, 2017REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, June 17, 2017REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, June 17, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, April 29, 2017TEAS SECTION 8 & 9 RECEIVED
Saturday, April 29, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, April 29, 2017COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, November 11, 2013NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Monday, November 11, 2013REGISTERED - SEC. 8 (6-YR) ACCEPTED
Monday, October 28, 2013REGISTERED - SEC. 8 (6-YR) FILED
Thursday, November 7, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, October 28, 2013TEAS SECTION 8 RECEIVED
Monday, October 28, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 28, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, September 11, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 29, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, February 12, 2008PUBLISHED FOR OPPOSITION
Wednesday, January 23, 2008NOTICE OF PUBLICATION
Wednesday, January 9, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 9, 2008ASSIGNED TO LIE
Friday, November 23, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 9, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 9, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 9, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 9, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 9, 2007NON-FINAL ACTION E-MAILED
Wednesday, May 9, 2007NON-FINAL ACTION WRITTEN
Thursday, May 3, 2007ASSIGNED TO EXAMINER
Tuesday, January 23, 2007NOTICE OF PSEUDO MARK MAILED
Monday, January 22, 2007NEW APPLICATION ENTERED

Related Keywords

disorders nervous system peripherial central preparation treatment pharmaceutical